Talk Drug

Viagra is doping

.

This year, the International Olympic Committee to take more stringent than in the past means to crack down on doping, but doping practices and types constant renovation. In September next year, Viagra may be on the prohibited list.

Recently, Viagra has been closely tracking by World Anti-Doping Agency (WADA). They are investigating whether Viagra is potential doping. And WADA has pointed out that some endurance athletes enhanced athletic ability through Viagra in Beijing Olympic Games.

Next month, the International Olympic Committee will re-test the Beijing Olympic Games athletes’ urine by the new method. The sports involved mainly are track and field, swimming and other endurance.

Samples of all the Beijing Olympic Games will be saved for 8 years, once new detection methods, the sample will be re-opened bottle at any time.

109 British male suspect died after taking Viagra

It is reported that 109 British male be killed because of taking Viagra since Viagra has been on market.

UK Drugs and Health Products Authority said that among the 109 deaths, there are 44 people were killed by heart attack and 29 people are killed by sudden death. In addition, the report did not mention the reasons of the death of 36 individuals.

NICPBP visited to USPC

Be invited by the CEO of USPC (The United States Pharmacopoeia Commission), NICPBP (National Institute for the Control of Pharmaceutical and Biological Products) visited to the United States Pharmacopoeia Commission on March 3.

Sino-US made a deep discussion on specific matters related to cooperation and signed the second round memorandum of cooperation formally. The areas of cooperation include collaborative calibration standard materials, the research and development of the analytical methods and analytical techniques, counterfeit drug detection methods and techniques, quality control of biological products as well as technical personnel exchanges and so on.

The entourage includes drug experts from NICPBP and Drug laboratory personnels from Liaoning Province, Shaanxi Province, Wuhan City etc..

Wohua Pharmaceuticals: 11 drug formulations through GMP certification

Wohua Pharmaceuticals today announced that China FDA recently issued to the “GMP pharmaceutical certificate”, that all 11 drug formulations through the GMP certification.

It is reported that the 11 formulations include tablets, oral liquid, hard capsules, granules, pills, wine agent, tincture, powder, syrup, mixture, etc..

Shandong Wohua Pharmaceuticals Technology Corporation (hereinafter to be referred as Wohua Pharma) is a Chinese patent medicine and health care products manufacture with more than a hundred years’ history which may be dated back to the Wanhetang Pharmacy in Emperor QianLong’s reign (1736-1796) during the Qing Dynasty (1644-1911). The Wanhetang Pharmacy of that period was renowned throughout the center in Shandong Province. It had a drug store in front and a pharmaceutical factory at the back. After China’s liberation and the private property being transformed, the Chinese Medicine (CM) Processing Section of Wanhetang Pharmacy integrated with the Decoction Piece Group of Shandong Changwei Center Medicinal Material Company and Shandong Weifang Chinese Medicine Factory was established, realizing joint state-private ownership in January 1959. In February 2002, it was restructured as Weifang Wohua Pharmaceuticals Technology Co., Ltd. In March 2003, it changed as Shandong Wohua Pharmaceuticals Technology Corporation with the approval of Shandong People’s Government, among the key Chinese patent medicine manufacturers in Shandong and was listed on Shenzhen Stock Exchange on January 24th, 2007, the first listed pharmaceutical enterprise in Weifang.

International pharmaceutical giant gratifying performance in the financial crisis

Through collating some financial statements of inational pharmaceutical giants, I find that the pharmaceutical industry undertake less obvious impact by financial crisis.

The British pharmaceutical giant AstraZeneca announced in 2008 performance report showed that total sales growth of 3%.

French Sanofi – Aventis company performance in 2008 also exceeded expectations. The company’s full-year net sales is 27.568 billion euros, an increase of 3.7%, net profit of 7.186 billion euros, an increase of 3.2%.

Data show that in 2008 Novartis achieve net sales growth of 9 percent, reaching 41.5 billion U.S. dollars, operating income increased 32 percent, amounting to nine billion U.S. dollars, the annual profit of 8.2 billion U.S. dollars, an increase of 25%.

According to the analysis, the financial turmoil leads to global economic slowdown and weak demand. It is lack of consumer confidence and purchasing power has declined, but consumption of medicine is a rigid demand, less affected, so pharmaceutical companies can market relative good performance .

Zhongguancun biomedical industry grew rapidly in 2008

From January to November in 2008, the total industrial output value of Zhongguancun biomedical industry is 23.5 billion, increased 46.57 percent.

It is reported that in the first 11 months of 2008, Zhongguancun biomedical industry achieved total revenue of 38.1 billion yuan, grew up 40.94 percent. Among them, the exports reached 561 million U.S. dollars, grew up 128%. And the industry employed 62,254 people, an increase of 15.54%.

During the first 11 months of 2008, Zhongguancun biomedical enterprises applicated 1989 patents, of which invention patent applications 893, accounted for 76.60%.

The report also shows that in the first 11 months of 2008, Zhongguancun vaccines business achieved total revenue of 568 million yuan over the same period last year increased by one-third of.

The industry of medical devices grew stablely and it is the maximum areas.